10,000 heart patients enrolled in landmark study to personalize care
NCT ID NCT06216847
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study is following 10,000 people hospitalized with confirmed or suspected coronary heart disease across multiple centers. Researchers are collecting detailed data on diagnoses, treatments, and outcomes to see which real-world strategies work best. The goal is to move away from one-size-fits-all care and find better ways to prevent heart attacks and strokes.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors personalize treatment for coronary heart disease, potentially reducing heart attacks and strokes.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new drug or cure. Results may take years and might not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE (CHD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Hospital of Northern Theater Command
RECRUITINGShenyang, Liaoning, 110016, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an AI trained on real heart patients outsmart generic chatbots?
- Can your smartwatch replace a medical heart test? scientists put apple watch to the test
- Yam gruel shows promise for heart health after stent surgery
- Heart patients may need only one blood thinner after balloon treatment, major trial tests
- Exercise test may reveal hidden heart dangers in 15,000 patients
- Heart patients get rehab via smartphone app in new study